Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangqin Fu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
AAPS Pharmscitech|September 21, 2021
Stability Evaluation of Lyotropic Liquid Crystalline Precursor for the Co-delivery of Chlorhexidine and Silver NanoparticlesFangqin Fu, Xin Li, Tengyi Zheng, et al.
Acta Pharmaceutica Sinica. B|May 17, 2021
Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept studyWenhao Wang, Zhengwei Huang, Yanbei Li, et al.
ACS Nano|May 16, 2022
Inhalable Biomimetic Protein Corona-Mediated Nanoreactor for Self-Amplified Lung Adenocarcinoma Ferroptosis TherapyWenhao Wang, Fangqin Fu, Zhengwei Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2020
Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary deliveryZhengwei Huang, Ying Huang, Wenhua Wang, et al.
Advanced Drug Delivery Reviews|April 26, 2022
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approachesWenhao Wang, Zhengwei Huang, Ying Huang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
AAPS Pharmscitech|September 21, 2021
Stability Evaluation of Lyotropic Liquid Crystalline Precursor for the Co-delivery of Chlorhexidine and Silver NanoparticlesFangqin Fu, Xin Li, Tengyi Zheng, et al.
Acta Pharmaceutica Sinica. B|May 17, 2021
Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept studyWenhao Wang, Zhengwei Huang, Yanbei Li, et al.
ACS Nano|May 16, 2022
Inhalable Biomimetic Protein Corona-Mediated Nanoreactor for Self-Amplified Lung Adenocarcinoma Ferroptosis TherapyWenhao Wang, Fangqin Fu, Zhengwei Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2020
Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary deliveryZhengwei Huang, Ying Huang, Wenhua Wang, et al.
Advanced Drug Delivery Reviews|April 26, 2022
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approachesWenhao Wang, Zhengwei Huang, Ying Huang, et al.
Pageof 2